Castration Resistant Prostate Cancer
Castration Resistant Prostate Cancer (CRPC) is a form of prostate cancer that continues to grow despite hormone therapy aimed at lowering testosterone levels, leading to more aggressive disease progression.
Mevrometostat for Relapsed/Refractory Cancers
We are testing Mevrometostat in patients with relapsed or refractory small cell lung cancer, castration-resistant prostate cancer, and follicular lymphoma. The goal is to see how well it works in these challenging cases.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Small Cell Lung Cancer
Small Cell Lung Cancer (SCLC) is a fast-growing type of lung cancer that is often associated with smoking and tends to spread quickly to other parts of the body.
Follicular Lymphoma
Follicular Lymphoma (FL) is a type of non-Hodgkin lymphoma that typically grows slowly and affects the lymphatic system, often presenting with swollen lymph nodes.
Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL) is an aggressive form of non-Hodgkin lymphoma characterized by the rapid growth of large B-cells in the lymphatic system.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Specialized Hospital For Active Treatment Of Oncology Haskovo EOOD
Department of Medical Oncology
Haskovo, Bulgaria
Complex Oncological Center Plovdiv EOOD
Department of Medical Oncology and Oncological Diseases in Gastroenterology
Plovdiv, Bulgaria
Complex Oncology Center Ruse EOOD
Department of Medical Oncology
Ruse, Bulgaria
Sponsor: Pfizer Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.